FR2522328B1 - Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments - Google Patents

Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments

Info

Publication number
FR2522328B1
FR2522328B1 FR8203338A FR8203338A FR2522328B1 FR 2522328 B1 FR2522328 B1 FR 2522328B1 FR 8203338 A FR8203338 A FR 8203338A FR 8203338 A FR8203338 A FR 8203338A FR 2522328 B1 FR2522328 B1 FR 2522328B1
Authority
FR
France
Prior art keywords
ceto
steroids
medicaments
application
preparation process
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8203338A
Other languages
English (en)
Other versions
FR2522328A1 (fr
Inventor
Daniel Philibert
Jean Georges Teutsch
Germain Costerousse
Roger Deraedt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR8203338A priority Critical patent/FR2522328B1/fr
Priority to SE8300308A priority patent/SE8300308L/
Priority to MA19934A priority patent/MA19716A1/fr
Priority to ZA83982A priority patent/ZA83982B/xx
Priority to IL67920A priority patent/IL67920A0/xx
Priority to US06/469,042 priority patent/US4477445A/en
Priority to PH28558A priority patent/PH21308A/en
Priority to GR70610A priority patent/GR78465B/el
Priority to DK89783A priority patent/DK89783A/da
Priority to PCT/FR1983/000034 priority patent/WO1983003099A1/fr
Priority to EG133/83A priority patent/EG15881A/xx
Priority to NL8300738A priority patent/NL8300738A/nl
Priority to KR1019830000853A priority patent/KR880001870B1/ko
Priority to CA000422503A priority patent/CA1206471A/fr
Priority to YU00478/83A priority patent/YU47883A/xx
Priority to MX8310507U priority patent/MX7199E/es
Priority to AU11913/83A priority patent/AU562739B2/en
Priority to IT47820/83A priority patent/IT1197592B/it
Priority to PT76307A priority patent/PT76307B/fr
Priority to BE0/210223A priority patent/BE896042A/fr
Priority to SU833561503A priority patent/SU1340593A3/ru
Priority to CH1099/83A priority patent/CH657368A5/fr
Priority to FI830652A priority patent/FI80049C/fi
Priority to LU84667A priority patent/LU84667A1/fr
Priority to DE19833307143 priority patent/DE3307143A1/de
Priority to GB08305558A priority patent/GB2118186B/en
Priority to IE429/83A priority patent/IE54748B1/en
Priority to ES520195A priority patent/ES8401495A1/es
Priority to JP58031909A priority patent/JPS58201800A/ja
Priority to HU83690A priority patent/HU193269B/hu
Priority to AR83292260A priority patent/AR241187A1/es
Priority to AT0071183A priority patent/AT396109B/de
Publication of FR2522328A1 publication Critical patent/FR2522328A1/fr
Priority to OA58138A priority patent/OA07567A/fr
Priority to US06/618,590 priority patent/US4540686A/en
Priority to CA000486788A priority patent/CA1215353A/fr
Application granted granted Critical
Publication of FR2522328B1 publication Critical patent/FR2522328B1/fr
Priority to FR888814868A priority patent/FR2639045B2/fr
Priority to US07/438,359 priority patent/US5064822A/en
Priority to JP2046023A priority patent/JPH02275895A/ja
Priority to US07/757,261 priority patent/US5182381A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J61/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by contraction of only one ring by one or two atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0016—Oximes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/0025—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16
    • C07J7/003—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/0065—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
    • C07J7/0075—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified substituted in position 17 alfa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
FR8203338A 1982-03-01 1982-03-01 Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments Expired FR2522328B1 (fr)

Priority Applications (39)

Application Number Priority Date Filing Date Title
FR8203338A FR2522328B1 (fr) 1982-03-01 1982-03-01 Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments
SE8300308A SE8300308L (sv) 1982-03-01 1983-01-21 Nya 3-keto- 4,9,19-nor-stereoider, deras framstellning, deras anvendning som lekemedel, kompositioner innehallande dem och deras nya erhallna mellanprodukter
MA19934A MA19716A1 (fr) 1982-03-01 1983-02-11 Procede de preparation de nouveaux derives 3- ceto a 4,9 19- norsteroides .
ZA83982A ZA83982B (en) 1982-03-01 1983-02-14 3-ceto delta 4,9 19-nor steroid derivatives,their preparation their use as medicaments,the compositions containing them and the intermediates thus obtained
IL67920A IL67920A0 (en) 1982-03-01 1983-02-15 New derivatives of 3-keto delta 4,9,19-nor steroids,their preparation,their application as medicaments,the compositions containing them and the new intermediates obtained
US06/469,042 US4477445A (en) 1982-03-01 1983-02-23 3-Keto-19-nor-Δ4,9-steroids
PH28558A PH21308A (en) 1982-03-01 1983-02-23 3-keto-19-nor-/4,9-steroids
GR70610A GR78465B (fr) 1982-03-01 1983-02-25
DK89783A DK89783A (da) 1982-03-01 1983-02-25 Fremgangsmaade til fremstilling af 3-keto-delta4,9-19-nor-steroidderivater
PCT/FR1983/000034 WO1983003099A1 (fr) 1982-03-01 1983-02-25 3-ceto-delta 4,9-19-norsteroides
EG133/83A EG15881A (en) 1982-03-01 1983-02-27 Process for preparing of new products of 3-aceto delta 4,9,19 steroids
CH1099/83A CH657368A5 (fr) 1982-03-01 1983-02-28 Derives de 3-ceto delta-4,9 19-nor-steroides, leur preparation, les compositions les renfermant et les produits de depart pour leur preparation.
CA000422503A CA1206471A (fr) 1982-03-01 1983-02-28 Procede de preparation de nouveaux derives 3-ceto .delta.4,9 19-nor steroides
YU00478/83A YU47883A (en) 1982-03-01 1983-02-28 Process for obtaining new 3-keto-delta-4,9,19-nor steroid derivatives
MX8310507U MX7199E (es) 1982-03-01 1983-02-28 Procedimiento para preparar derivados de 3-cetodelta-4,9,19-nor-esteroides
AU11913/83A AU562739B2 (en) 1982-03-01 1983-02-28 3 keto delta4,9,19-nor steroid derivatives
IT47820/83A IT1197592B (it) 1982-03-01 1983-02-28 Derivati di 3-cheto delta 4,9 19-nor-steroidi,procedimento per la loro preparazione,loro impiego come medicamenti,composizioni che li contengono ed intermedi ottenuti
PT76307A PT76307B (fr) 1982-03-01 1983-02-28 Procede de preparation de nouveaux derives 3-ceto delta 4,9 19-nor steroides
BE0/210223A BE896042A (fr) 1982-03-01 1983-02-28 Nouveaux derives de 3-ceto delta 4,9, 19-nor-steroides, leur preparation, leur application comme medicaments, les compositions les renfermant et les nouveaux intermediaires obtenus
SU833561503A SU1340593A3 (ru) 1982-03-01 1983-02-28 Способ получени производных @ @ 19-норстероидов
NL8300738A NL8300738A (nl) 1982-03-01 1983-02-28 Nieuwe derivaten van 3-keto-delta4.9-19-nor-steroiden, de bereiding daarvan, de toepassing daarvan als geneesmiddelen, de preparaten, die deze verbindingen bevatten, en de verkregen nieuwe intermediairen.
FI830652A FI80049C (fi) 1982-03-01 1983-02-28 Foerfarande foer framstaellning av terapeutiskt anvaendbara 19-nor-/ 4,9-steroider.
LU84667A LU84667A1 (fr) 1982-03-01 1983-02-28 Nouveaux derives de 3-ceto delta 4,9 19-nor-steroides,leur preparation,leur application comme medicament,les compositions les reinfermant et les nouveaux intermediaires obtenus
KR1019830000853A KR880001870B1 (ko) 1982-03-01 1983-02-28 3-케토 △ 4,9,19-노르 스테로이드 유도체의 제조방법
GB08305558A GB2118186B (en) 1982-03-01 1983-03-01 11-substituted steroid 4,9-dienes and 4-ene-9,10-epoxides
DE19833307143 DE3307143A1 (de) 1982-03-01 1983-03-01 Neue derivate der 3-keto-(delta)-4,9,19-nor-steroide, deren herstellung, deren verwendung als arzneimittel, die diese enthaltenden zusammensetzungen und erhaltene neue zwischenprodukte
IE429/83A IE54748B1 (en) 1982-03-01 1983-03-01 Steroid compounds
ES520195A ES8401495A1 (es) 1982-03-01 1983-03-01 Procedimiento para preparar nuevos derivados de 3-ceto- 4,9,19-nor-esteroides.
JP58031909A JPS58201800A (ja) 1982-03-01 1983-03-01 ３―ケト―δ↑４‖↑９―１９―ノルステロイドの新誘導体、それらの製造法及びそれらを含む製薬組成物
HU83690A HU193269B (en) 1982-03-01 1983-03-01 Process for preparing 3-oxo-delta up 4,9 - and 3-oxo-delta up 4-9,11-epoxy-19-norsteroids
AR83292260A AR241187A1 (es) 1982-03-01 1983-03-01 Procedimiento para la preparacion de nuevos productos derivados de la estructura 3-ceto delta-4,9-19-nor esteroides e intermediarios para uso exclusivo en dicho procedimiento.
AT0071183A AT396109B (de) 1982-03-01 1983-03-01 Verfahren zur herstellung neuer 3-keto-delta 4,9,19-norsteroid-derivate
OA58138A OA07567A (fr) 1982-03-01 1983-10-13 3-céto-delta 4,9-19-norstéroides.
US06/618,590 US4540686A (en) 1982-03-01 1984-06-08 3-Keto-19-nor-Δ4,9 -steroids
CA000486788A CA1215353A (fr) 1982-03-01 1985-07-15 PROCEDE POUR LA PREPARATION DE DERIVES DE 3-CETO 5.alpha.- HYDROXY .DELTA.9 19-NORSTEROIDES ET LES DERIVES AINSI OBTENUS
FR888814868A FR2639045B2 (fr) 1982-03-01 1988-11-16 Nouveaux produits derives de la structure 3-ceto-delta-4,9-19-nor steroides et leur application comme medicaments
US07/438,359 US5064822A (en) 1982-03-01 1989-11-16 Novel 3-keto-19-nor-Δ4,9 -steroids
JP2046023A JPH02275895A (ja) 1982-03-01 1990-02-28 ３―ケト―△↑９―１９―ノルステロイドの新誘導体
US07/757,261 US5182381A (en) 1982-03-01 1991-09-10 Intermediates for 3-keto-19-nor-Δ4,9 -steroids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8203338A FR2522328B1 (fr) 1982-03-01 1982-03-01 Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments

Publications (2)

Publication Number Publication Date
FR2522328A1 FR2522328A1 (fr) 1983-09-02
FR2522328B1 true FR2522328B1 (fr) 1986-02-14

Family

ID=9271439

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8203338A Expired FR2522328B1 (fr) 1982-03-01 1982-03-01 Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments

Country Status (32)

Country Link
US (2) US4477445A (fr)
JP (2) JPS58201800A (fr)
KR (1) KR880001870B1 (fr)
AR (1) AR241187A1 (fr)
AT (1) AT396109B (fr)
AU (1) AU562739B2 (fr)
BE (1) BE896042A (fr)
CA (1) CA1206471A (fr)
CH (1) CH657368A5 (fr)
DE (1) DE3307143A1 (fr)
DK (1) DK89783A (fr)
EG (1) EG15881A (fr)
ES (1) ES8401495A1 (fr)
FI (1) FI80049C (fr)
FR (1) FR2522328B1 (fr)
GB (1) GB2118186B (fr)
GR (1) GR78465B (fr)
HU (1) HU193269B (fr)
IE (1) IE54748B1 (fr)
IL (1) IL67920A0 (fr)
IT (1) IT1197592B (fr)
LU (1) LU84667A1 (fr)
MA (1) MA19716A1 (fr)
MX (1) MX7199E (fr)
NL (1) NL8300738A (fr)
PH (1) PH21308A (fr)
PT (1) PT76307B (fr)
SE (1) SE8300308L (fr)
SU (1) SU1340593A3 (fr)
WO (1) WO1983003099A1 (fr)
YU (1) YU47883A (fr)
ZA (1) ZA83982B (fr)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2528434B1 (fr) * 1982-06-11 1985-07-19 Roussel Uclaf Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament
US5182381A (en) * 1982-03-01 1993-01-26 Roussel Ulcaf Intermediates for 3-keto-19-nor-Δ4,9 -steroids
FR2639045B2 (fr) * 1982-03-01 1994-07-29 Roussel Uclaf Nouveaux produits derives de la structure 3-ceto-delta-4,9-19-nor steroides et leur application comme medicaments
DE3231827A1 (de) * 1982-08-24 1984-03-01 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-aryl-17(alpha)-alkinyl-17ss-hydroxy-4,9(10)- estradien-3-on-derivate, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3461090D1 (en) * 1983-02-18 1986-12-04 Schering Ag 11-beta-aryl-estradienes, process for their preparation and pharmaceutical compositions containing them
IT1212835B (it) * 1983-08-18 1989-11-30 Lehner Ag Derivati di acidi biliari, procedimento per la loro preparazione e relative composizioni farmaceutiche.
DE3347126A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-aryl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
US4666898A (en) * 1983-12-28 1987-05-19 Jackson Lab. Treatment of obesity, diabetes and other symptoms of hypercorticoidism using etiocholanolones
DE3410880A1 (de) * 1984-03-21 1985-10-03 Schering AG, Berlin und Bergkamen, 1000 Berlin 17-substituierte estradiene und estratriene
DE3438500C1 (de) * 1984-10-18 1986-05-28 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung 11ß-substituierter Δ↑9↑-19-Norsteroide
FR2573657B1 (fr) * 1984-11-29 1989-05-12 Roussel Uclaf Produit comprenant une substance antiprogestomimetique et une substance uterotonique
FR2576025B1 (fr) * 1985-01-14 1987-01-23 Roussel Uclaf Nouveaux steroides substitues en position 10, leur procede et les intermediaires de preparation, leur application comme medicaments, les compositions pharmaceutiques les contenant
AU580843B2 (en) * 1985-02-07 1989-02-02 Schering Aktiengesellschaft 11``-phenyl-gonanes, their manufacture and pharmaceutical preparations containing them
CA1241947A (fr) * 1985-05-31 1988-09-13 Pierre R. Proulx Derives de sterol-polyene pour sondes de membranes
GB8513723D0 (en) * 1985-05-31 1985-07-03 Erba Farmitalia 11-beta substituted steroids
US4686214A (en) * 1985-10-30 1987-08-11 Alcon Laboratories, Inc. Anti-inflammatory compounds for ophthalmic use
FR2598421B1 (fr) * 1986-05-06 1988-08-19 Roussel Uclaf Nouveaux produits 19-nor ou 19-nor d-homo steroides substitues en position 11b par un radical phenyle portant un radical alkynyle, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
DE3625315A1 (de) * 1986-07-25 1988-01-28 Schering Ag 11ss-(4-isopropenylphenyl)-estra-4,9-diene, deren herstellung und diese enthaltende pharmazeutische praeparate
US4774236A (en) * 1986-09-17 1988-09-27 Research Triangle Institute 17α-(substituted-methyl)-17β-hydroxy/esterified hydroxy steroids and pharmaceutical compositions containing them
US5272140A (en) * 1987-01-23 1993-12-21 Akzo N.V. 11-aryl steroid derivatives
FR2610933B1 (fr) * 1987-02-18 1989-06-09 Roussel Uclaf Nouveaux 19-nor steroides substitues en position 7, leur preparation, leur application comme medicaments, les compositions pharmaceutiques les renfermant
US5446178A (en) * 1987-03-18 1995-08-29 Schering Aktiengesellschaft Process for preparing 19,11β-bridged steroids
DE3708942A1 (de) * 1987-03-18 1988-09-29 Schering Ag 19,11ss-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
US5075464A (en) * 1987-04-22 1991-12-24 Merrell Dow Pharmaceuticals Inc. 17β-(cyclopropylamino)androstene derivatives
DE3723788A1 (de) * 1987-07-16 1989-01-26 Schering Ag 11(beta)-phenyl-4,9,15-estratriene, deren herstellung und diese enthaltende pharmazeutische praeparate
FR2618783B1 (fr) * 1987-07-30 1991-02-01 Roussel Uclaf Nouveaux 17-aryle steroides, leurs procedes et des intermediaires de preparation comme medicaments et les compositions pharmaceutiques les renfermant
FR2620707B1 (fr) * 1987-09-18 1989-12-08 Roussel Uclaf Nouveaux steroides comportant un cycle spirannique a 3, 4 ou 6 chainons en position 17, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
US4954490A (en) * 1988-06-23 1990-09-04 Research Triangle Institute 11 β-substituted progesterone analogs
DE3822770A1 (de) * 1988-07-01 1990-01-04 Schering Ag 13-alkyl-11ss-phenylgonane
EP0369881A1 (fr) * 1988-11-16 1990-05-23 Roussel-Uclaf Nouveaux produits dérivés de la structure 3-céto delta-4,9 19-nor stéroides et leur application comme médicaments
FR2643638B1 (fr) * 1989-02-24 1991-06-14 Roussel Uclaf Nouveaux 19-nor steroides ayant en position 11beta une chaine carbonee comportant une fonction amide ou carbamate, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
US6790971B1 (en) * 1989-02-24 2004-09-14 Aventis Pharma S.A. 19-Nor-steroids
FR2665901B2 (fr) * 1989-02-24 1994-07-29 Roussel Uclaf Nouveaux 19-nor sterouides ayant en position 11beta une chaine carbonee comportant une fonction amide, leur preparation, leur application comme medicaments.
EP0411733B1 (fr) * 1989-08-04 1998-10-21 Schering Aktiengesellschaft 11-Bêta-aryl-gona-4,9-diène-3-ones
US5276023A (en) * 1989-08-08 1994-01-04 Roussel Uclaf 19-nor-steroid esters
FR2651435A1 (fr) * 1989-09-07 1991-03-08 Roussel Uclaf Nouvelle utilisation de composes anti-progestomimetiques.
FR2659233B1 (fr) * 1990-03-06 1994-01-21 Roussel Uclaf Nouvelle utilisation de composes anti-progestomimetiques chez les animaux d'elevage.
DE4008584A1 (de) * 1990-03-15 1991-09-26 Schering Ag Verfahren zur herstellung von zwischenprodukten fuer die antigestagensynthese (onapristonsynthese)
DE4042004A1 (de) * 1990-12-22 1992-06-25 Schering Ag 14(beta)-h-, 14- u. 15-en-11(beta)-aryl-4-estrene
US5407928A (en) * 1990-08-15 1995-04-18 Schering Aktiengesellschaft 11β-aryl-gona-4,9-dien-3-ones
JP3029907B2 (ja) * 1991-12-20 2000-04-10 理化学研究所 抗肥満剤
JP3862295B2 (ja) * 1993-09-30 2006-12-27 独立行政法人理化学研究所 抗肥満剤
US5420120A (en) * 1993-12-17 1995-05-30 Alcon Laboratories, Inc. Anti-inflammatory glucocorticoid compounds for topical ophthalmic use
US5780220A (en) * 1994-05-19 1998-07-14 Trustees Of The University Of Pennsylvania Methods and compositions for inhibiting HIV replication
DK0683172T3 (da) * 1994-05-19 1998-03-30 Akzo Nobel Nv 11,21-bisphenyl-19-norpregnanderivater
US5639598A (en) * 1994-05-19 1997-06-17 The Trustees Of The University Of Pennsylvania Method and kit for identification of antiviral agents capable of abrogating HIV Vpr-Rip-1 binding interactions
DE4434488A1 (de) * 1994-09-14 1996-03-21 Schering Ag Steroidester und -amide, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
US5929262A (en) * 1995-03-30 1999-07-27 The United States Of America As Represented By The Department Of Health And Human Services Method for preparing 17α-acetoxy-11β-(4-N, N-dimethylaminophyl)-19-Norpregna-4,9-diene-3, 20-dione, intermediates useful in the method, and methods for the preparation of such intermediates
IL118974A (en) * 1995-08-17 2001-09-13 Akzo Nobel Nv History 11 - (Transformed Phenyl) - Astra - 4, 9 - Diane, their preparation and pharmaceutical preparations containing them
US6900193B1 (en) * 1996-05-01 2005-05-31 The United States Of America As Represented By The Department Of Health And Human Services Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents
US6861415B2 (en) * 1996-05-01 2005-03-01 The United States Of America As Represented By The Department Of Health And Human Services 21-substituted progesterone derivatives as new antiprogestational agents
IL122740A (en) * 1997-01-15 2003-09-17 Akzo Nobel Nv 16-hydroxy-11-(substituted phenyl)-estra-9,4-diene derivatives, their preparation and pharmaceutical compositions containing them
DE19745085A1 (de) * 1997-10-11 1999-04-15 Jenapharm Gmbh 11ß-Benzaldoxim-9alpha,10alpha-epoxy-estr-4-en-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
US6531462B2 (en) 1997-11-06 2003-03-11 Riken Medicament for treating obesity and improving lipid metabolism
JP3873097B2 (ja) * 1997-11-06 2007-01-24 独立行政法人理化学研究所 抗肥満剤及び脂質代謝改善剤
US6020328A (en) 1998-03-06 2000-02-01 Research Triangle Institute 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US6262042B1 (en) 1998-05-29 2001-07-17 Research Triangle Institute 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
DK1265911T3 (da) * 2000-03-17 2008-09-29 Us Gov Health & Human Serv 17-alfa-substitueret-11-beta-substitueret-4-aryl og 21-substitueret 19-norpregnadiendion som antiprogestationelle midler
US7250408B2 (en) * 2002-12-16 2007-07-31 Bayer Schering Pharma Ag Glucocorticoid receptor antagonists for prophylaxis and therapy of glucocorticoid-mediated hypogonadism, of sexual dysfunction and/or infertility
AU2004217988C1 (en) * 2003-02-28 2010-06-03 Southwest Foundation For Biomedical Research Method for preparing 17 alpha-acetoxy-11beta-(4-N,N-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, intermediates thereof, and methods for the preparation of such intermediates
KR20060052709A (ko) * 2003-06-20 2006-05-19 바이럴 게노믹스, 인크. 항바이러스 조성물 및 그의 사용 방법
TWI477276B (zh) 2008-04-28 2015-03-21 Repros Therapeutics Inc 抗黃體素給藥方案
DE102009034525A1 (de) * 2009-07-21 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
CA2793712A1 (fr) * 2010-03-22 2011-09-29 Repros Therapeutics Inc. Compositions et procedes pour l'apport non toxique d'antiprogestines
PL2576582T3 (pl) 2010-05-26 2020-06-29 Corcept Therapeutics, Inc. Leczenie dystrofii mięśniowej
SG11201407397WA (en) 2012-05-31 2014-12-30 Repros Therapeutics Inc Formulations and methods for vaginal delivery of antiprogestins
WO2014070517A1 (fr) 2012-11-02 2014-05-08 Repros Therapeutics Inc. Méthodes et compositions de traitement d'affections dépendant de la progestérone
CA2933590C (fr) * 2013-12-11 2023-10-03 Sloan-Kettering Institute For Cancer Research Inhibiteurs de glucocorticoides pour le traitement du cancer de la prostate
AU2016226451B2 (en) 2015-03-02 2019-12-19 Corcept Therapeutics, Inc. Use of glucocorticoid receptor antagonist and somatostatin analogues to treat ACTH-secreting tumors
KR102495223B1 (ko) 2015-03-30 2023-02-01 코어셉트 쎄라퓨틱스 인코포레이티드 부신기능부전을 치료하기 위한 글루코코르티코이드와 조합된 글루코코르티코이드 수용체 길항제의 용도
EP3335043B1 (fr) 2015-08-13 2021-03-31 Corcept Therapeutics, Inc. Procédé permettant d'établir un diagnostic différentiel du syndrome de cushing en fonction de l'hormone adrénocorticotrope (acth)
US11124537B2 (en) 2015-12-23 2021-09-21 Oric Pharmaceuticals, Inc. Inhibitors of glucocorticoid receptor
WO2017112904A1 (fr) * 2015-12-23 2017-06-29 Oric Pharmaceuticals, Inc. Inhibiteurs de récepteurs glucocorticoïdes
US11208432B2 (en) 2015-12-23 2021-12-28 Oric Pharmaceuticals, Inc. Inhibitors of glucocorticoid receptor
EP3405101B1 (fr) 2016-01-19 2020-12-23 Corcept Therapeutics, Inc. Diagnostic différentiel du syndrome de cushing ectopique
WO2018068021A1 (fr) 2016-10-07 2018-04-12 Oric Pharmaceuticals, Inc. Inhibiteurs de récepteurs glucocorticoïdes
WO2022130015A2 (fr) 2020-12-18 2022-06-23 Instil Bio (Uk) Limited Traitement de lymphocytes infiltrant les tumeurs

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH571537A5 (fr) * 1970-04-24 1976-01-15 Sandoz Ag
CH558346A (de) * 1971-06-17 1975-01-31 Sandoz Ag Verfahren zur herstellung neuer 3-oximino-17(alpha)-propadienyl-substituierter steroide.
BE787898A (fr) * 1971-08-26 1973-02-23 Roussel Uclaf Nouveaux composes steroides trieniques et procede de preparation
DE2636405C2 (de) * 1976-08-12 1982-07-08 Schering Ag, 1000 Berlin Und 4619 Bergkamen Δ↑1↑↑5↑-17α-Chloräthinyl- und -Propinylsteroide der Östranreihe, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Präparate
FR2377417A1 (fr) * 1977-01-13 1978-08-11 Roussel Uclaf Nouveaux derives steroides substitues en 11b, ainsi que leur procede de preparation
FR2377419A1 (fr) * 1977-01-13 1978-08-11 Roussel Uclaf Nouveaux derives steroides 11b-substitues 1,3,5 (10) trieniques, leur procede de preparation et leur application comme medicament
FR2377418A1 (fr) * 1977-01-13 1978-08-11 Roussel Uclaf Nouveaux derives steroides 4,9-dieniques 11b-substitues, leur procede de preparation et leur application comme medicaments
FR2495621A1 (fr) * 1980-12-05 1982-06-11 Roussel Uclaf Nouveaux derives de l'estra 4,9-diene, leur procede de preparation et leur application comme medicaments
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained

Also Published As

Publication number Publication date
DE3307143A1 (de) 1983-09-08
US4540686A (en) 1985-09-10
YU47883A (en) 1986-04-30
SE8300308D0 (sv) 1983-01-21
US4477445A (en) 1984-10-16
IL67920A0 (en) 1983-06-15
CA1206471A (fr) 1986-06-24
HU193269B (en) 1987-09-28
JPS58201800A (ja) 1983-11-24
NL8300738A (nl) 1983-10-03
FI830652A0 (fi) 1983-02-28
ES520195A0 (es) 1983-12-01
SE8300308L (sv) 1983-09-02
BE896042A (fr) 1983-08-29
GR78465B (fr) 1984-09-27
ZA83982B (en) 1984-03-28
FI830652L (fi) 1983-09-02
GB2118186B (en) 1986-04-23
PH21308A (en) 1987-09-28
KR840003649A (ko) 1984-09-15
AT396109B (de) 1993-06-25
AU1191383A (en) 1983-09-08
PT76307A (fr) 1983-03-01
EG15881A (en) 1991-06-30
GB8305558D0 (en) 1983-03-30
JPH02275895A (ja) 1990-11-09
CH657368A5 (fr) 1986-08-29
IE830429L (en) 1983-09-01
ATA71183A (de) 1992-10-15
PT76307B (fr) 1986-01-27
GB2118186A (en) 1983-10-26
SU1340593A3 (ru) 1987-09-23
ES8401495A1 (es) 1983-12-01
MX7199E (es) 1987-12-23
AU562739B2 (en) 1987-06-18
JPH054397B2 (fr) 1993-01-19
AR241187A1 (es) 1992-01-31
WO1983003099A1 (fr) 1983-09-15
KR880001870B1 (ko) 1988-09-23
FI80049B (fi) 1989-12-29
IT8347820A0 (it) 1983-02-28
FI80049C (fi) 1990-04-10
MA19716A1 (fr) 1983-10-01
DK89783D0 (da) 1983-02-25
DK89783A (da) 1983-09-02
IT1197592B (it) 1988-12-06
FR2522328A1 (fr) 1983-09-02
JPH0443920B2 (fr) 1992-07-20
IE54748B1 (en) 1990-01-31
LU84667A1 (fr) 1983-09-08

Similar Documents

Publication Publication Date Title
FR2522328B1 (fr) Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments
IT8323841A0 (it) Nuovi esteri di 1,4-diidropiridine e processi per la loro preparazione.
SG18588G (en) Anti-inflammatory products derived from methylene-diphosphonic acid, and process for their preparation
FR2644789B1 (fr) Nouveaux steroides 19-nor, 3-ceto comportant une chaine en 17 aminosubstituee, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
FR2603586B1 (fr) Composes derives de l'imidazoquinolinylether, et leur procede de preparation
FR2514769B1 (fr) Dipropionate de beclomethasone, son procede de preparation et compositions pharmaceutiques le contenant
FR2596395B1 (fr) Nouveaux steroides comportant un cycle spirannique en position 17, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
FR2639045B2 (fr) Nouveaux produits derives de la structure 3-ceto-delta-4,9-19-nor steroides et leur application comme medicaments
FR2644788B1 (fr) Nouveaux steroides 3-ceto comportant une chaine en 17 amino-substituee, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
IL82231A0 (en) 1-hydroxy-2-pyridones,process for their preparation,and pharmaceutical compositions which contain them and intermediates formed in the preparation of the 1-hydroxy-2-pyridones
IL56612A (en) 1-aryloxy-3-nitratoalkylamino-2-propanols,process for their preparation,and pharmaceutical compositions comprising them
IL76889A0 (en) Solubilised platinum compound,method for the production thereof and pharmaceutical compositions containing the same
IL58377A (en) 4-phenyl-1,3-benzodiazepines,method of preparing the same and pharmaceutical compositions comprising them
BE877197A (fr) Procede de preparation de derives de 14,15-methylene de la serie des oestranes
FR2656309B1 (fr) Nouveaux produits sterouides comportant en position 10, un radical ethyle substitue, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
FR2644787B1 (fr) Nouveaux steroides 21 aminosubstitues, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
FR2436144B1 (fr) Nouveaux derives d'aurones, leur procede de preparation et leur utilisation comme produits pharmaceutiques
FR2556721B1 (fr) Nouveaux derives de o-mercaptopropanamide d'o amino-acides, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
FR2566779B2 (fr) Nouveaux derives steroides substitues en 11b, leur procede de preparation et leur application comme medicaments
FR2539126B1 (fr) Derives amino-alcoyl-sulfoniques, leur procede de preparation, et compositions pharmaceutiques en renfermant
MA19909A1 (fr) Procede de preparation de nouveaux derives dichlores de la serie 16a-methyl pregnane.
FR2612921B1 (fr) Composes derives du meta-aminophenol, leur procede de preparation
FR2573077B1 (fr) Nouveaux derives thiosulfonates, leur procede de preparation ainsi que les compositions pharmaceutiques les contenant
FR2586021B1 (fr) Nouveaux produits derives de la structure 5a-oh d 9(10) 19-nor steroides
FR2617481B1 (fr) Nouveaux derives de la tetrahydropyridine, leur procede de preparation et les intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant

Legal Events

Date Code Title Description
ST Notification of lapse